Trial Profile
A prospective, longitudinal, registry study assessing long term effect testosterone replacement therapy with testosterone undecanoate in hypogonadal men
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 22 Dec 2015 New trial record